Adaarsh Pharmacon Industries Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 3.21 Cr
as on 13-12-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 42.59 Cr
as on 13-12-2024
- Satisfied Charges ₹ 30.00 Cr
as on 13-12-2024
- Revenue %
(FY 2023)
- Net Worth -350.45%
(FY 2023)
- Total Assets 50.47%
(FY 2023)
About Adaarsh Pharmacon Industries
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.21 Cr.
The company currently has active open charges totaling ₹42.59 Cr. The company has closed loans amounting to ₹30.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dattatraya Patil and Laxmi Patil serve as directors at the Company.
- CIN/LLPIN
U24303KA2020PTC134914
- Company No.
134914
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Gulbarga, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Adaarsh Pharmacon Industries?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dattatraya Patil  | Managing Director | 15-Jun-2020 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Laxmi Patil | Director | 15-Jun-2020 | Current |
Financial Performance of Adaarsh Pharmacon Industries.
Adaarsh Pharmacon Industries Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 350.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Adaarsh Pharmacon Industries?
Unlock access to Adaarsh Pharmacon Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Sep 2023 | ₹42.59 Cr | Open |
Karnataka Bank Ltd. Creation Date: 10 Oct 2022 | ₹5.00 Cr | Satisfied |
Karnataka Bank Ltd. Creation Date: 24 Sep 2021 | ₹25.00 Cr | Satisfied |
How Many Employees Work at Adaarsh Pharmacon Industries?
Adaarsh Pharmacon Industries has a workforce of 51 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adaarsh Pharmacon Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adaarsh Pharmacon Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
